← Back to headlines
Eli Lilly's Next-Gen Obesity Drug Advances, Wall Street Stumbles
Eli Lilly's next-generation weight-loss shot has cleared another regulatory hurdle, signaling progress in its development. Meanwhile, Wall Street experienced a stumble, partly influenced by surging oil prices.
23 Jul, 10:45 — 23 Jul, 18:35
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
cnbc
Center1
Center (1)
bloomberg
Right
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
bloombergHigh11h ago
Eli Lilly’s Next-Generation Weight-Loss Shot Clears Another Hurdle - Bloomberg.com
Eli Lilly’s Next-Generation Weight-Loss Shot Clears Another Hurdle Bloomberg.com
Read full article →cnbcMostly Factual3h ago
Wall Street stumbles as oil surges, and Lilly takes a new path on next-gen obesity drug
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
Read full article →Coverage Timeline
First report: bloomberg · 23 Jul, 10:45|Full coverage: 2 · 8h|Window: 8h
Left-leaningCenterRight-leaning
